Please login to the form below
29
Revenue 2017Soliris
The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Soliris was produced by Alexion.
AstraZeneca latest to sue US government over Medicare drug price negotiation plan
As well as drugs for rare diseases, many cancer treatments, including AZ’s Lynparza (olaparib) and Soliris (eculizumab), are launched first in an orphan indication and are then expanded over time
Roche reports positive results for crovalimab as rare blood disease treatment
C5 inhibitors can be effective in treating the condition. This includes AstraZeneca/Alexion's Soliris (eculizumab), which was approved by the US Food and Drug Administration in 2007 and has subsequently ... Like Soliris, crovalimab is also a C5 inhibitor,
Alexion's Ultomiris shows promise in neuromyelitis optica spectrum disorder phase 3 trial
Instead Ultomiris was compared to the external placebo arm from the company’s pivotal Soliris PREVENT clinical trial.
Amgen announces positive results for Solaris biosimilar for paroxysmal nocturnal haemoglobinuria
The study met its primary endpoints, showing ABP 959 to be as effective as Soliris on key measures of disease activity. ... Critically, the safety and immunogenicity profile of ABP 959 was comparable to Soliris.
FDA approves Alexion’s Ultomiris for generalised myasthenia gravis
As presented at the 2022 American Academy of Neurology Annual Meeting, Ultomiris has demonstrated clinical benefit through 60 weeks, with treatment every eight weeks, compared to Soliris every two weeks.”.
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
Subscribe to our email news alerts
- Top 10 benefits of virtual advisory boards: Save Time and Resources
- NIHR launches new framework to highlight health progress outcomes
- Johns Hopkins and National Cancer Unit develop new genetic risk-scoring method for major diseases
- UKHSA secures UK-based vaccine deal for future influenza pandemics
- Novo Nordisk and Valo Health agree deal worth up to $3.3bn to develop cardiovascular treatments
- Landscape review reveals £1.1bn of UK funding for rare diseases
No results were found
PMHub
Anthem PR
With a rare strength in media and influencer relations, Anthem’s award-winning team offers a fresh approach to health PR...
Latest intelligence
- The importance of accelerating clinical trial diversity
- Diversity shouldn’t be an afterthought – it’s an investment in the credibility of scientific endeavour...
- Digital Opinion Leaders: The Role of Influencers in Medical Communications
- There are many informed, knowledgeable HCPs who talk about a disease state online, but not all of them are influencers. This paper explores who digital opinion leaders are and how...
- Creating Hope Though Action – World Suicide Prevention Day
- At Mednet Group, we believe that actions speak louder than words. That's why we're getting behind this year's Suicide Prevention Day campaign of 'creating hope through action'....
